Skip to main content
MEHA
NASDAQ Life Sciences

Functional Brands Adjourns Critical Shareholder Meeting Due to Lack of Quorum, Reschedules for June 1

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Food & Beverage Stocks · Consumer
Sentiment info
Negative
Importance info
8
Price
$0.075
Mkt Cap
$3.419M
52W Low
$0.057
52W High
$8
52W Position info
32% above low
Off High info
99% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

MEHA sits 32% above its 52-week low of $0.057 on light trading volume (0.4× avg).

Summary

Functional Brands Inc. adjourned its Special Meeting of Stockholders due to insufficient quorum, delaying a critical vote likely related to its proposed reverse stock split to avoid Nasdaq delisting. The meeting is rescheduled for June 1, 2026.


Key Events · Corporate Governance and Compliance · MEHA

  • Special Meeting Adjourned

    The Special Meeting of Stockholders, where critical proposals (likely including a reverse stock split to avoid delisting) were to be voted on, was adjourned due to a lack of quorum.

  • Meeting Rescheduled

    The meeting has been reconvened for Monday, June 1, 2026, at 10:00 a.m. Pacific Time, with no changes to the proposals.

  • Shareholder Urgency

    The company is strongly encouraging eligible stockholders who have not yet voted to do so promptly to ensure a quorum is met.

  • Delisting Threat Context

    This delay comes as the company seeks shareholder approval for a reverse stock split, a measure previously disclosed as necessary to maintain its Nasdaq listing.


Analysis · MEHA · Life Sciences

This 8-K indicates a significant hurdle for Functional Brands as it attempts to execute a critical strategy to avoid Nasdaq delisting. The inability to secure a quorum for its Special Meeting, which was expected to address a proposed reverse stock split, signals potential shareholder apathy or resistance. The delay pushes back a crucial decision point for the company's listing status, adding uncertainty and pressure. Failure to pass the reverse stock split could lead to delisting, a severe blow for a micro-cap company already facing financial challenges and a going concern warning.

How filings like this one have moved

In the 30 days to Oct 1, 2026, 35.9% of the 1030 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, MEHA was trading at $0.08 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.4M. The 52-week trading range was $0.06 to $8.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MEHA - Latest Insights

MEHA
Aug 17, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.004847
Real-time Price: $0.0052 info
Change: +$0.000353 (+7%) info
Market Cap: $337.59K info
MEHA
Aug 14, 2026, 4:01 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.0049
Real-time Price: $0.0052 info
Change: +$0.0003 (+6%) info
Market Cap: $337.59K info
MEHA
Jul 02, 2026, 4:16 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.0043
Real-time Price: $0.0052 info
Change: +$0.0009 (+21%) info
Market Cap: $337.59K info
MEHA
Jun 30, 2026, 6:46 PM EDT
Filing Type: 8-K
Importance Score:
10
Price at Filing: $0.0052
Real-time Price: $0.0052 info
Change: $0 (0%) info
Market Cap: $337.59K info
MEHA
Jun 15, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
10
Price at Filing: $0.0416
Real-time Price: $0.0052 info
Change: -$0.0364 (-88%) info
Market Cap: $337.59K info